Morningside Ventures VC

Investments by market, targeted sectors and preferred funding rounds

Name - Morningside Ventures
Description -
Investor Type - VC
Preferred rounds -
Location - Hong Kong, China

Investments by industry

healthtech - 57%
biotech - 43%

Number of investments: 7

Morningside Ventures invested in PhoreMost during a round worth $46,000,000 - 3/23/2021
Morningside Ventures invested in Innodem Neurosciences during a round worth $6,000,000 - 1/20/2021
Morningside Ventures invested in NewAmsterdam Pharma during a round worth $196,000,000 - 1/14/2021
Morningside Ventures invested in Curai Health during a round worth $27,500,000 - 12/16/2020
Morningside Ventures invested in Everlywell during a round worth $175,000,000 - 12/3/2020
Morningside Ventures invested in Gracell Biotechnologies during a round worth $100,000,000 - 10/29/2020
Morningside Ventures invested in Immune Regulation during a round worth £40,600,000 - 9/21/2020